Published in Ann Rheum Dis on May 01, 1992
[The future of methotrexate therapy and other folate inhibitors]. Z Rheumatol (2011) 0.75
Efficacy of low-dose methotrexate in rheumatoid arthritis. N Engl J Med (1985) 3.37
How many joints in the hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis? Arthritis Rheum (1985) 2.68
The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum (1990) 2.59
Therapeutic suppression of tissue reactivity. II. Effect of aminopterin in rheumatoid arthritis and psoriasis. Am J Med Sci (1951) 2.40
Methotrexate in rheumatoid arthritis. Toxic effects as the major factor in limiting long-term treatment. Arthritis Rheum (1989) 1.36
Immunologic studies of rheumatoid arthritis patients treated with methotrexate. Arthritis Rheum (1987) 1.34
The effects of leucovorin (folinic acid) on methotrexate therapy in rheumatoid arthritis patients. Arthritis Rheum (1988) 1.25
Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression. Arthritis Rheum (1990) 1.20
Methotrexate in rheumatoid arthritis. Indications, contraindications, efficacy, and safety. Ann Intern Med (1987) 1.16
Prospective long term follow-up of methotrexate therapy in rheumatoid arthritis: toxicity, efficacy and radiological progression. Br J Rheumatol (1989) 1.09
Toxicity of methotrexate in rheumatoid arthritis. J Rheumatol (1987) 1.08
Inhibition of leukotriene B4 synthesis in neutrophils from patients with rheumatoid arthritis by a single oral dose of methotrexate. Arthritis Rheum (1990) 1.01
Methotrexate therapy in rheumatoid arthritis patients diminishes lectin-induced mononuclear cell proliferation. Rheumatol Int (1990) 0.90
Methotrexate in rheumatoid arthritis: a prospective study in Israeli patients with immunogenetic correlations. Ann Rheum Dis (1988) 0.89
Phase II trial of 10-deaza-aminopterin in patients with advanced colorectal cancer. Am J Clin Oncol (1983) 0.79
Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med (1997) 8.65
Biologically active carbazole alkaloids from Murraya koenigii. J Agric Food Chem (1999) 4.43
Supplementation with folic acid during methotrexate therapy for rheumatoid arthritis. A double-blind, placebo-controlled trial. Ann Intern Med (1994) 3.53
Interleukins and IgA synthesis. Human and murine interleukin 6 induce high rate IgA secretion in IgA-committed B cells. J Exp Med (1989) 3.28
Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity. Nat Med (2001) 2.87
The effect of folic acid supplementation on the toxicity of low-dose methotrexate in patients with rheumatoid arthritis. Arthritis Rheum (1990) 2.59
Biochemical relationship of thymocyte mitogenic factor and factors enhancing humoral and cell-mediated immune responses. J Immunol (1978) 2.28
Death resulting from overzealous total parenteral nutrition: the refeeding syndrome revisited. Am J Clin Nutr (1981) 2.20
An enzymatic method for preparation of dissociated murine Peyer's patch cells enriched for macrophages. J Immunol Methods (1982) 2.06
Molecular and cellular mechanisms of joint destruction in rheumatoid arthritis: two cellular mechanisms explain joint destruction? Ann Rheum Dis (1993) 1.98
Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis. Arthritis Rheum (1989) 1.95
Antioxidant and antiinflammatory activities of anthocyanins and their aglycon, cyanidin, from tart cherries. J Nat Prod (1999) 1.94
Accessory cells in murine Peyer's patch. I. Identification and enrichment of a functional dendritic cell. J Exp Med (1983) 1.92
The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain (1999) 1.91
Recombinant murine IL-5 induces high rate IgA synthesis in cycling IgA-positive Peyer's patch B cells. J Immunol (1988) 1.80
Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J Clin Invest (1986) 1.70
Prevention of MIF activity by agents known to increase cellular cyclic AMP. J Immunol (1973) 1.64
Hospital malnutrition. A prospective evaluation of general medical patients during the course of hospitalization. Am J Clin Nutr (1979) 1.63
Dairy foods and bone health: examination of the evidence. Am J Clin Nutr (2000) 1.62
Correlation of serologic indicators of inflammation with effectiveness of nonsteroidal antiinflammatory drug therapy in rheumatoid arthritis. Arthritis Rheum (1990) 1.61
T cell receptor peptide vaccination in rheumatoid arthritis: a placebo-controlled trial using a combination of Vbeta3, Vbeta14, and Vbeta17 peptides. Arthritis Rheum (1998) 1.55
The solid-phase synthesis of polyglutamates of folic acid. Biochemistry (1969) 1.55
Development of clinical criteria for osteoarthritis. J Rheumatol (1987) 1.46
Local and systemic effects of cigarette smoking on folate and vitamin B-12. Am J Clin Nutr (1994) 1.45
Cyclic adenosine 3',5'-monophosphate in human lung. Biochim Biophys Acta (1971) 1.44
Production of predominantly polymeric IgA by human peripheral blood lymphocytes stimulated in vitro with mitogens. J Exp Med (1980) 1.44
Modulation of liposomal membrane fluidity by flavonoids and isoflavonoids. Arch Biochem Biophys (2000) 1.42
[General anesthesia combined with peridural anesthesia in a case of Steinert's disease]. Rev Esp Anestesiol Reanim (1992) 1.40
Incidence of three cross-reactive idiotypes on human rheumatoid factor paraproteins. J Immunol (1988) 1.39
In vivo immune response to a T-cell-dependent antigen by cultures of disassociated murine Peyer's patch. Proc Natl Acad Sci U S A (1982) 1.39
Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch Biochem Biophys (1998) 1.38
Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries. Phytomedicine (2001) 1.37
Antioxidant and cyclooxygenase inhibitory phenolic compounds from Ocimum sanctum Linn. Phytomedicine (2000) 1.35
Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J Nutr (1997) 1.35
Structure-activity relationships for antioxidant activities of a series of flavonoids in a liposomal system. Free Radic Biol Med (1998) 1.33
Isotype specificity of helper T cell clones. Peyer's patch Th cells preferentially collaborate with mature IgA B cells for IgA responses. J Exp Med (1984) 1.31
Murine Peyer's patch T cell clones. Characterization of antigen-specific helper T cells for immunoglobulin A responses. J Exp Med (1982) 1.30
Effects of phenytoin on folic-acid conjugases in man. Lancet (1969) 1.30
Novel bioactivities of Curcuma longa constituents. J Nat Prod (1998) 1.30
Biologic agents for treating rheumatoid arthritis. Concepts and progress. Arthritis Rheum (1997) 1.26
Preferential induction of polyclonal IgA secretion by murine Peyer's patch dendritic cell-T cell mixtures. J Exp Med (1984) 1.26
Characterization of human Fas gene. Exon/intron organization and promoter region. J Immunol (1995) 1.25
In vitro synthesis of IgM rheumatoid factor by lymphocytes from healthy adults. J Immunol (1980) 1.24
Seronegative rheumatoid arthritis. A distinct immunogenetic disease? Arthritis Rheum (1982) 1.22
Suppression of rheumatoid factor production by methotrexate in patients with rheumatoid arthritis. Evidence for differential influences of therapy and clinical status on IgM and IgA rheumatoid factor expression. Arthritis Rheum (1990) 1.20
Somatic mutation and CDR3 lengths of immunoglobulin kappa light chains expressed in patients with rheumatoid arthritis and in normal individuals. J Clin Invest (1995) 1.16
Evidence for the identification of lymphocyte activating factor as the adherent cell-derived mediator responsible for enhanced antibody synthesis by nude mouse spleen cells. Cell Immunol (1978) 1.16
Analysis of human IgG and IgA subclass antibody-secreting cells from localized chronic inflammatory tissue. J Immunol (1989) 1.16
Sleep apnea in patients with myasthenia gravis. Neurology (2006) 1.14
Osteopontin, a substrate for transglutaminase and factor XIII activity. Biochem Biophys Res Commun (1991) 1.13
A new instrument for the rapid preparation of tissue slices. Anal Biochem (1980) 1.12
Polygammaglutamyl metabolites of methotrexate. Biochem Biophys Res Commun (1973) 1.12
Association of a low molecular weight helper factor(s) with thymocyte proliferative activity. J Immunol (1977) 1.11
Airways disease in rheumatoid arthritis patients. One element of a general exocrine dysfunction. Arthritis Rheum (1987) 1.11
The natural history of multiple sclerosis: a geographically based study: 8: familial multiple sclerosis. Brain (2000) 1.10
Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: toxicity and dose finding trial in refractory rheumatoid arthritis. J Rheumatol (1996) 1.08
Toxicity of methotrexate in rheumatoid arthritis. J Rheumatol (1987) 1.08
Metabolism of daidzein and genistein by intestinal bacteria. J Nat Prod (1995) 1.07
Super in vitro synergy between inhibitors of dihydrofolate reductase and inhibitors of other folate-requiring enzymes: the critical role of polyglutamylation. Cancer Res (1998) 1.06
The immunoglobulin kappa light chain repertoire expressed in the synovium of a patient with rheumatoid arthritis. Arthritis Rheum (1992) 1.06
Acquisition of resistance to antifolates caused by enhanced gamma-glutamyl hydrolase activity. Cancer Res (1993) 1.06
Etiopathogenesis of the rheumatoid arthritis-like disease in MRL/l mice. I. The histomorphologic basis of joint destruction. Arthritis Rheum (1985) 1.04
Naturally occurring folates. Ann N Y Acad Sci (1971) 1.04
Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. Phytomedicine (2000) 1.03
Rheumatoid arthritis associated with expanded populations of granular lymphocytes. Ann Intern Med (1986) 1.03
The identification of poly-gamma-glutamyl chain lengths in bacterial folates. Biochemistry (1974) 1.03
Enhanced in vitro synthesis of IgM rheumatoid factor in rheumatoid arthritis. Arthritis Rheum (1980) 1.03
Trichotillometry: the quantitation of hair pluckability as a method of nutritional assessment. Am J Clin Nutr (1981) 1.03
Bioactive N-isobutylamides from the flower buds of Spilanthes acmella. Phytochemistry (1999) 1.02
Degradation products of cyanidin glycosides from tart cherries and their bioactivities. J Agric Food Chem (2001) 1.02
Clinically significant valvular heart disease in systemic lupus erythematosus. Am J Med (1988) 1.02
Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives. Am J Clin Nutr (1982) 1.01
Novel antioxidant compounds from tart cherries (Prunus cerasus). J Nat Prod (1999) 1.00
Suppression of in vitro monoclonal human rheumatoid factor synthesis by antiidiotypic antibody. Target cells and molecular requirements. J Clin Invest (1983) 0.99
A potassium-channel toxin from the sea anemone Bunodosoma granulifera, an inhibitor for Kv1 channels. Revision of the amino acid sequence, disulfide-bridge assignment, chemical synthesis, and biological activity. Eur J Biochem (1997) 0.99
Antifolates in rheumatoid arthritis: a hypothetical mechanism of action. Clin Exp Rheumatol (1993) 0.99
Abnormal glycosylation of serum IgG from patients with chronic inflammatory diseases. Arthritis Rheum (1988) 0.99
X-linked dominant hereditary motor and sensory neuropathy. Brain (1990) 0.98
Central lesions in chronic inflammatory demyelinating polyneuropathy: an MRI study. Neurology (1990) 0.98
Biosynthesis of riboflavine in Corynebacterium species: the purine precursor. J Bacteriol (1969) 0.98
Radioactive assay of folic acid polyglutamate conjugase(s). Anal Biochem (1970) 0.98
Antioxidant polyphenols from tart cherries (Prunus cerasus). J Agric Food Chem (1999) 0.98
DR antigen distribution in Blacks with rheumatoid arthritis. J Rheumatol (1983) 0.97
Identification and partial purification of two synergistically acting helper mediators in human mixed leukocyte culture supernatants. J Immunol (1977) 0.97
Harmful effect of megadoses of vitamins: electroencephalogram abnormalities and seizures induced by intravenous folate in drug-treated epileptics. Am J Clin Nutr (1975) 0.97
IgA rheumatoid factor synthesis by dissociated synovial cells. Characterization and relationship to IgM rheumatoid factor synthesis. Arthritis Rheum (1985) 0.97
Mapping the gene for acetazolamide responsive hereditary paryoxysmal cerebellar ataxia to chromosome 19p. Hum Mol Genet (1995) 0.97
Effects of folate deficiency and supplementation on methylnitrosourea-induced rat mammary tumors. J Natl Cancer Inst (1992) 0.97
Field use of hair epilation force in nutrition status assessment. Am J Clin Nutr (1982) 0.96
In vitro regulation of IgA subclass synthesis. I. Discordance between plasma cell production and antibody secretion. J Exp Med (1982) 0.96
Prostaglandin inhibition of the immunologic release of slow reacting substance of anaphylaxis in the rat. Proc Soc Exp Biol Med (1971) 0.96
In vitro antibacterial activity of faeriefungin, a new broad-spectrum polyene macrolide antibiotic. Antimicrob Agents Chemother (1990) 0.96
Differential patterns of in vitro IgM rheumatoid factor synthesis in seronegative and seropositive rheumatoid arthritis. Arthritis Rheum (1982) 0.96
Evidence of antigen receptor-influenced oligoclonal B lymphocyte expansion in the synovium of a patient with longstanding rheumatoid arthritis. J Clin Invest (1994) 0.96
The role of mitochondrial OXPHOS dysfunction in the development of neurologic diseases. Neurobiol Dis (2012) 0.95